Press Release: Gelteq Appoints Dr. Paul Wynne as Chief Scientific Officer to Propel Innovative Ingestible Gel Technology

Dow JonesDec 19, 2024 08:30 ET

Express News | Gelteq Appoints DR. Paul Wynne as Chief Scientific Officer to Propel Innovative Ingestible Gel Technology

ReutersDec 19, 2024 08:30 ET

Gelteq Receives FDA Approval of Its Suitability Petition for New Animal Drug

GlobeNewswireDec 17, 2024 08:30 ET

Express News | Gelteq Limited Shares Halted To The Upside; Stock Now Up 49.44%

BenzingaDec 10, 2024 09:42 ET

Gelteq to Participate in the Benchmark Company 13th Annual Discovery Investor Conference

GlobeNewswireDec 9, 2024 08:30 ET

12 Health Care Stocks Moving In Tuesday's Pre-Market Session

BenzingaDec 3, 2024 16:05 ET